Fundraising FoxFront Range Biosciences
Boulder, US · Founded 2015 · Delaware corporation · 12 known investors
Find your way into Front Range Biosciences
Sign up to find every way you can get introduced to Front Range Biosciences
- Your email: who you already know at Front Range Biosciences, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Front Range Biosciences team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
US-focused tissue culture cloning and biotech.
Founders & leadership
Front Range Biosciences was founded in 2015 by Christopher Zalewski, Jonathan Vaught, and Nick Hofmeister.
Investors · 12
KEY Investment Partnerslisted by KEY Investment PartnersDenver
How we know: KEY Investment Partners's portfolio page · Not right? Tell us
HALLEY Venture PartnersreportedSan Francisco
How we know: funding news · prnewswire.com · Not right? Tell us
Phyto PartnersreportedBoca Raton
How we know: funding news · prnewswire.com · Not right? Tell us
Salveo CapitalreportedNorthbrook
How we know: funding news · prnewswire.com · Not right? Tell us
Sand Hill AngelsreportedMenlo Park · $50K – $2M
How we know: funding news · press coverage · Not right? Tell us
Also in the syndicate · 3
Harvard Business School Alumni Angels of New YorkSand Hill Angels XVI, LLCWelcan Capital
Reported raises · per SEC filings
Form D private placements$45M disclosed across 6 rounds · 2016–2020
▶$18.7MraisedFeb 2020 · 55 investors · OtherRule 506(b)
▶$18.7MraisedFeb 2020 · 55 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Nick HofmeisterExecutive Officer, Director
- William MilitelloDirector
- Jonathan VaughtExecutive Officer, Director
- Marc RiiskaDirector
- Ephraim LindenbaumDirector
- Offering amount
- $40.3M
- Amount sold
- $18.7M
- Proceeds to insiders
- $125K
- First sale
- Jan 2020
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$8.5MraisedSep 2019 · 55 investors · OtherRule 506(b)
▶$8.5MraisedSep 2019 · 55 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- William MilitelloDirector
- Nicholas HofmeisterExecutive Officer, Director
- Ephraim LindenbaumDirector
- Jonathan VaughtExecutive Officer, Director
- Offering amount
- $8.5M
- Amount sold
- $8.5M
- First sale
- Jul 2019
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$15.9MraisedOct 2018 · 87 investors · OtherRule 506(b)
▶$15.9MraisedOct 2018 · 87 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Jonathan VaughtExecutive Officer, Director, Promoter
- Nicholas HofmeisterExecutive Officer, Director, Promoter
- Douglas WolfordDirector
- Ephraim LindenbaumDirector
- Christopher ZalewskiPromoter
- Offering amount
- $15.9M
- Amount sold
- $15.9M
- First sale
- Jul 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$372.5KraisedJun 2017 · 12 investors · OtherRule 506(b)
▶$372.5KraisedJun 2017 · 12 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Jonathan VaughtExecutive Officer, Director, Promoter
- Ephraim LindenbaumDirector
- Nick HofmeisterExecutive Officer, Director, Promoter
- Offering amount
- $3M
- Amount sold
- $372.5K
- First sale
- Jun 2017
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$1.5MraisedMar 2017 · 26 investors · OtherRule 506(b)
▶$1.5MraisedMar 2017 · 26 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Jonathan VaughtExecutive Officer, Director, Promoter
- Christopher ZalewskiExecutive Officer, Director, Promoter
- Nick HofmeisterExecutive Officer, Director, Promoter
- Offering amount
- $1.5M
- Amount sold
- $1.5M
- First sale
- May 2016
- Incorporated
- Corporation, Colorado, 2015
- Federal exemptions
- 06b
▶$10KraisedNov 2016 · 1 investors · OtherRule 506(b)
▶$10KraisedNov 2016 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Christopher ZalewskiExecutive Officer, Director, Promoter
- Jonathan VaughtExecutive Officer, Director, Promoter
- Nick HofmeisterExecutive Officer, Director, Promoter
- Offering amount
- $1M
- Amount sold
- $10K
- First sale
- Mar 2016
- Incorporated
- Corporation, Colorado, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Front Range Biosciences do?
- US-focused tissue culture cloning and biotech.
- Who founded Front Range Biosciences?
- Front Range Biosciences was founded by Christopher Zalewski, Jonathan Vaught, Nick Hofmeister in 2015.
- Who are Front Range Biosciences's investors?
- Front Range Biosciences's investors include KEY Investment Partners, AFI Capital Partners, Arcadian Capital, HALLEY Venture Partners, Militello Capital, New York Angels, Phyto Partners, Salveo Capital and 1 more.
- How much funding has Front Range Biosciences raised?
- Front Range Biosciences has disclosed $45M raised across 6 rounds.
- Where is Front Range Biosciences headquartered?
- Front Range Biosciences is headquartered in Boulder, US.